Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

CDT Equity (CDT) SEC Filings & 10K Form

CDT Equity logo
$1.54 -0.01 (-0.65%)
Closing price 08/21/2025 04:00 PM Eastern
Extended Trading
$1.52 -0.02 (-0.97%)
As of 08:47 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent CDT Equity SEC Filings

Export to Excel
DateFilerForm TypeView
08/18/2025
3:42 PM		CDT Equity Inc. (Subject)
CDT Equity Inc. (Subject)
CDT Equity Inc. (Subject)
CDT Equity (Subject)
CDT Equity Inc. (Subject)
Sarborg Ltd (Filed by)
Form SCHEDULE 13G/A
08/14/2025
12:11 PM		CDT Equity Inc. (Filer)
CDT Equity Inc. (Filer)
CDT Equity Inc. (Filer)
CDT Equity (Filer)
CDT Equity Inc. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2025
3:15 PM		CDT Equity Inc. (Filer)
CDT Equity Inc. (Filer)
CDT Equity Inc. (Filer)
CDT Equity (Filer)
CDT Equity Inc. (Filer)
Form 424B3
08/11/2025
4:12 PM		CDT Equity Inc. (Filer)
CDT Equity Inc. (Filer)
CDT Equity Inc. (Filer)
CDT Equity (Filer)
CDT Equity Inc. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/07/2025
11:15 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form EFFECT
07/31/2025
6:46 PM		CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CDT Equity (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Corvus Capital Ltd. (Filed by)
Form SCHEDULE 13D/A
07/09/2025
11:04 AM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form DEF 14A
07/08/2025
4:24 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form ARS
06/13/2025
6:17 AM		CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CDT Equity (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Corvus Capital Ltd. (Reporting)
Regan Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:30 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2025
7:45 AM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2025
4:35 PM		CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CDT Equity (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Sarborg Ltd (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/07/2025
4:36 PM		CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CDT Equity (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Sarborg Ltd (Filed by)
Form SCHEDULE 13G
05/06/2025
3:30 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2025
11:15 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form EFFECT
04/25/2025
3:30 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2025
4:24 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
04/17/2025
3:05 PM		Charles Faith L. (Reporting)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CDT Equity (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2025
4:14 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form PRE 14A
04/10/2025
5:00 AM		ASTRAZENECA PLC (Filed by)
ASTRAZENECA PLC (Filed by)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CDT Equity (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Form SCHEDULE 13G/A
04/01/2025
8:04 PM		Charles Faith L. (Reporting)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CDT Equity (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
8:07 PM		CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CDT Equity (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Farley Chele Chiavacci (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
8:09 PM		CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CDT Equity (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Fry Simon Jeremy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
8:13 PM		CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CDT Equity (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Lewis-Hall Freda C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
4:23 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2025
3:54 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/10/2025
3:30 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 424B5
03/06/2025
7:30 AM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2025
3:32 PM		CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CDT Equity (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Nirland Ltd (Filed by)
Form SCHEDULE 13G/A
02/19/2025
8:00 AM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 424B5
02/12/2025
11:15 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form EFFECT
02/11/2025
7:00 AM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2025
4:19 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/06/2025
7:58 AM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 424B5
02/05/2025
4:30 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/23/2025
7:15 AM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2025
4:00 PM		CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CDT Equity (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Nirland Ltd (Filed by)
Form SCHEDULE 13G
01/15/2025
3:30 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 424B5
12/20/2024
4:05 PM		CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CDT Equity (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Fry Simon Jeremy (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/20/2024
4:06 PM		CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CDT Equity (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Fry Simon Jeremy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
4:06 PM		CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CDT Equity (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Lewis-Hall Freda C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
"I'm risking my reputation on this" (Ad)

The wealth transfer most people will miss Whether you have $50 or $50,000, this blueprint can work for you.tc pixel

Get your FREE copy + $788 in bonuses (just cover nominal s&h) >>
12/20/2024
4:06 PM		Charles Faith L. (Reporting)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CDT Equity (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
4:06 PM		CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CDT Equity (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Farley Chele Chiavacci (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
4:00 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2024
4:15 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2024
4:01 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 424B3
12/09/2024
7:30 AM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form DEF 14A
12/08/2024
11:15 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form EFFECT
12/09/2024
5:11 AM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 424B3
11/26/2024
4:21 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form PRE 14A
11/25/2024
4:10 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/25/2024
3:53 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
4:20 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
4:22 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 10-Q/A
11/14/2024
4:24 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 10-Q/A
11/14/2024
4:27 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
5:01 AM		CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CDT Equity (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
St George Street Capital (Filed by)
Form SC 13G/A
11/04/2024
4:20 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 424B3
11/04/2024
4:21 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 424B5
11/03/2024
11:15 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form EFFECT
11/01/2024
4:10 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form DEFA14A
11/01/2024
3:15 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
4:15 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form DEF 14A
10/28/2024
4:16 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form DEFA14A
10/28/2024
4:17 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form ARS
10/24/2024
5:12 AM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form S-3
Registration statement under Securities Act of 1933  
10/18/2024
3:15 PM		CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CDT Equity (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Nirland Ltd (Filed by)
Form SC 13G/A
10/16/2024
4:15 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form PRE 14A
10/15/2024
4:00 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2024
5:01 AM		ASTRAZENECA PLC (Filed by)
ASTRAZENECA PLC (Filed by)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CDT Equity (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Form SC 13G
10/07/2024
6:36 PM		CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CDT Equity (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Nirland Ltd (Filed by)
Form SC 13G/A
10/07/2024
6:38 PM		CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CDT Equity (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Dovet Ltd (Reporting)
Nirland Ltd (Reporting)
Rowland Master Trust (Reporting)
Stockton Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:02 PM		CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CDT Equity (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Dovet Ltd (Reporting)
Nirland Ltd (Reporting)
Rowland Master Trust (Reporting)
Stockton Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
3:59 PM		CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
CDT Equity (Subject)
CONDUIT PHARMACEUTICALS INC. (Subject)
Corvus Capital Ltd. (Filed by)
Form SC 13D/A
09/19/2024
4:01 PM		Algo Holdings, Inc. (Reporting)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
CDT Equity (Issuer)
CONDUIT PHARMACEUTICALS INC. (Issuer)
Corvus Capital Ltd. (Reporting)
Regan Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
3:41 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 424B3
09/16/2024
11:15 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form EFFECT
09/06/2024
4:00 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2024
3:44 PM		CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
CDT Equity (Filer)
CONDUIT PHARMACEUTICALS INC. (Filer)
Form S-1
Registration statement under Securities Act of 1933  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:CDT) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners
Silver’s Still Under $35… For Now.
Silver is trading around $33—but insiders are betting on a $70 breakout by year’s end. With supply shrinkin...
GoldenCrest Metals | Sponsoredtc pixel
One tiny company just cracked Google’s $19B problem
Google’s AI-powered search could cost $20 billion a year in electricity—nearly half its profits. But new resea...
True Market Insiders | Sponsoredtc pixel
What Steve Bannon revealed about Trump’s gold play
A Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...
Reagan Gold Group | Sponsoredtc pixel
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsoredtc pixel
[No Brainer Gold Play]: “Show me a better investment.”
A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...
Golden Portfolio | Sponsoredtc pixel
US attacks China, September 30?
The White House just ordered more than 400 government agencies to prepare for the next phase of America’s econ...
Stansberry Research | Sponsoredtc pixel
I trusted Trump and got screwed
Porter Stansberry says he got one thing wrong—and now millions of Americans could pay the price. After warning...
Porter & Company | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel